Page last updated: 2024-09-03

n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester and Cancer of Kidney

n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ab, O; Audette, CA; Chari, RV; Doherty, H; Erickson, HK; Goldmacher, VS; Johnson, H; Jones, GE; Kellogg, B; Kovtun, YV; Lai, KC; Lutz, RJ; Maloney, EK; Mayo, MF; Pinkas, J; Singh, R; Sun, X; Widdison, WC; Wilhelm, S1

Other Studies

1 other study(ies) available for n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester and Cancer of Kidney

ArticleYear
Antibody-maytansinoid conjugates designed to bypass multidrug resistance.
    Cancer research, 2010, Mar-15, Volume: 70, Issue:6

    Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Renal Cell; Cell Adhesion Molecules; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Female; Humans; Immunotoxins; Kidney Neoplasms; Maleimides; Maytansine; Mice; Mice, SCID; Polyethylene Glycols

2010